Home Authors Posts by Kenny Lin, MD, MPH
Kenny Lin, MD, MPH
Physicians are finding and treating thousands of pseudo-cancers that would not have otherwise been found and don't need to be treated.
How testosterone direct-to-consumer advertising helps pharma rake in the dough.
Childhood vaccinations, tobacco screening in adults, and counseling kids not to start smoking top the list of effective clinical preventive services.
HHS nominee and physician, Tom Price, signed a letter sent to prior HHS Secretary Kathleen Sebelius, making it clear he doesn't understand the basics of cancer epidemiology. Kenny Lin, MD thinks he might need a refresher course.
A family doc says, "If you are a primary care doc or clinician who works with the underserved, start asking people if they are registered to vote, then help them to do it." #VotingIsAVitalSign
A bipartisan group of state health policy leaders (Reforming States Group) recently released a letter to the incoming Administration that proposes a modest federal-state policy agenda designed to advance the Triple Aim.
When we label someone with an addiction a substance abuser, we send the message that the condition is less treatable and that the person is somehow to blame. Words matter.
Although HPV vaccine has been shown to be safe and effective at reducing infection with the virus that causes cervical and oropharyngeal cancers, vaccination rates in the US are so low they have been labeled a serious public health threat.
Would the airing of minority views within medical guidelines provide useful perspectives for patients, clinicians, or policymakers, or are conflicting guidelines from different organizations already confusing enough as it is?
Heart failure provides a good example of a non-cancer condition that benefits from palliative care, especially in its advanced stages.
One of the authors reported that his increased efficiency and net revenue more than made up for cost of training and paying for an additional medical assistant functioning as a scribe.
Several years ago, a few colleagues and I performed a systematic evidence review to help update the U.S. Preventive Services Task Force's recommendations on screening for prostate cancer.